¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Open-label"¿¡ ´ëÇÑ ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
open-label study A preliminary (Phase I) clinical trial in which all patients receive the experimental treatment.
Ãâó: www.nationalmssociety.org/O%20-%20R.asp
open-label study study in which subjects and investigators know which agent is being administered to each group during the trial period
Ãâó: www.venofer.com/VenoferHCP/Venofer_glossary.html
open-label study An experimental study involving the use of a medicine, the identity of which is known to the patient.
Ãâó:
open-label study A study in which all parties, (patient, physician and study coordinator) are informed of the drug and dose being administered. In an open-label study, none of the participants are given placebos. These are usually conducted with Phase I & II studies.
Ãâó: www.wcctrials.com/glossary.HTM
open-label study A study in which the investigator and the study participant are aware of the drug therapy received during the study.
Ãâó: www.lillytrials.com/docs/terminology.html
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á